H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.7% of adults in San Francisco have diagnosed diabetes — 2.3 points below the U.S. 12% figure. Census population 873,965. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed San Francisco clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a San Francisco storefront.
Skin Substitute Therapy Products in San Francisco, CA for clinics & physicians. Skin substitute therapy fo… Compliance support & pricing — contact Hawk Medical.
San Francisco is a city of 500k–1M (873,965 Census). CDC PLACES (2023, crude) estimates 9.7% of adults in San Francisco have diagnosed diabetes — 2.3 points below the U.S. 12% figure. Adult arthritis here is 16.7% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Skin Substitute Therapy Products notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For San Francisco we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 9.7% of adults in San Francisco have diagnosed diabetes — 2.3 points below the U.S. 12% figure.
Vendor consolidation is boring on purpose: one account, IFUs filed, JE articles mapped. 6.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 9.7% of adults — 2.3 points below the U.S. 12% figure. Obesity is 17.5%; arthritis is 16.7%. That is place-level BRFSS modeling, not a clinic census and not a San Francisco trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow Noridian Healthcare Solutions CTP articles. Mixing those codes is a billing error.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers skin substitute therapy products and which products they use.
If you operate in California and another MAC state, say it on the first call. JE will not port 1:1. We would rather split utilization than watch a sister clinic copy San Francisco tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in San Francisco, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for San Francisco is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for San Francisco — 2.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in San Francisco. Useful for joint-program math; still needs a diagnosis and privileging.
No San Francisco storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.